Lurasidone Hydrochloride Tablet, Film Coated
Product Images NDC 0904-7421

This text provides information about a medication called Lurasidone. Each blister pack of the medication contains 40 mg of Lurasidone hydrochloride. The usual dosage and storage instructions are also mentioned. The medication should be stored at a temperature of 20° to 25°C. Additionally, it states that the medication should be kept out of the reach of children. The manufacturer is Major Pharmaceuticals and it is distributed by MSN Pharmaceuticals Inc. The Medication Guide can be found on their website.*

This is a description of a medication called Lurasidone. Each tablet contains 60 mg of Lurasidone hydrochloride. The usual dosage and storage instructions are given. The medication should be kept in a tightly sealed, light-resistant container and stored between 20° to 25°C (68°F to 77°F). The text also includes a caution to keep the medication out of the reach of children. It mentions that a medication guide is available at www.majorpharmaceuticals.com. The medication is manufactured by MAIOR* PHARMACEUTICALS and distributed in Indianapolis, IN, USA.*

This is a description of a medication called Lurasidone Hydrochloride Tablets with a National Drug Code (NDC) of 0904-7424-46. The tablets contain 80 mg of lurasidone hydrochloride, which is equivalent to 74.49 mg of lurasidone. The usual dosage should be followed as per the package insert. The tablets should be stored at a temperature of 20°C to 25°C (68°F to 77°F) and dispensed in a tightly sealed container. It is important to keep this medication and all drugs out of the reach of children. The medication guide is available at the website majorpharmaceuticals.com. The manufacturing company is MSN Pharmaceuticals Inc. located in Piscataway, NJ, and the distribution is done by Major Pharmaceuticals in Indianapolis, IN.*

Impact of other drugs on Lurasidone Pharmacokinetics(PK): - Strong CYP3A4 Inhibitor: Ketoconazole 400 mg/day - significant increase in Cmax and AUC - Moderate CYP3A4 Inhibitor: Diltiazem 240 mg/day - moderate increase in Cmax and AUC - Strong CYP3A4 Inducer: Rifampin 600 mg/day - significant decrease in Cmax and AUC - Lithium 600 mg BID - no significant change in Cmax and AUC compared to Lurasidone alone Please note that the given text is incomplete, and additional information may be required for a comprehensive evaluation.*